Employment

The following information is aimed at those who have been affected by a leukaemia diagnosis and the associated issues raised with employment

Being or becoming employed

This information is designed to help you explore your rights, whatever your decision might be.

In employment but don’t want to/can’t continue

This information is designed to help you explore your rights, whatever your decision might be. This article looks at the decision to leave work.

Self-employment

This information is designed for people who are self-employed, either alone or running a small business.

Employment rights for parents of a child with leukaemia

There are over 1,600 children diagnosed with cancer in the UK each year – approximately a third are diagnosed with leukaemia. A leukaemia diagnosis has a huge impact on you, your child and the rest of your family - what follows is usually a very emotional and distressing time and lives are often turned upside down.

Make a donation

We receive no lottery or Government funding so we rely completely on our fundraisers to help us maintain our support services. Please see our examples of how your money can help.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

December 4th

How the Budget News Affects You, and Why We’ll Continue to Push for Change

It’s been around two weeks since the Chancellor of the Exchequer announced his Autumn Statement, setting out the spending priorities of the Government. In this blog, our Policy and Evidence Manager, Charlotte Crowley, reflects on the announcements and their impact on you. ...

October 31st

October Fundraising: Highlighting our community

With spooky season in full effect, we want to share some of the fang-tastic fundraising you have done this October in support of those living with Leukaemia....

October 20th

Leukaemia Care successfully campaigns for nationwide access to new chronic lymphocytic leukaemia treatment

The National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) have announced the approval of zanubrutinib on the NHS for patients with chronic lymphocytic leukaemia (CLL) in all nations of the UK....